Pathophysiological Interactions between Bronchial Asthma, Connective Tissue Dysplasia, and Pubertal Development: A Narrative Review
DOI:
https://doi.org/10.37506/z2tmav87Keywords:
Bronchial asthma, Connective tissue dysplasia, Puberty, Adolescents, Endocrine regulation, Inflammation.Abstract
Pubertal development is a complex neuroendocrine process regulated by activation of the hypothalamic–pituitary–gonadal
(HPG) axis and influenced by genetic, inflammatory, metabolic, and nutritional factors. Bronchial asthma (BA), one of the
most prevalent chronic inflammatory diseases in adolescence, has been associated with alterations in growth velocity and
pubertal timing, particularly in individuals with moderate-to-severe or poorly controlled disease. However, variability in
pubertal outcomes among affected adolescents suggests the presence of additional biological modifiers.
Undifferentiated connective tissue dysplasia (UCTD) is a genetically determined condition characterized by abnormalities
of collagen synthesis and extracellular matrix organization, resulting in multisystem involvement. Its high prevalence
among adolescents with BA indicates a potential role as a structural and biological modifier of endocrine development.
Current evidence suggests that the coexistence of BA and UCTD may amplify inflammatory burden and hypoxic stress.
It may also contribute to extracellular matrix instability and micronutrient deficiencies, including vitamin D, zinc, and
magnesium. Together, these interacting mechanisms may disrupt hormonal regulation of the HPG axis and contribute to
pubertal delay or disharmonious pubertal development.
Recognition of this combined pathology underscores the importance of multidisciplinary monitoring and early identification
of endocrine vulnerability in order to improve long-term reproductive outcomes.
Downloads
References
Plant TM, Witchel SF. Puberty in nonhuman primates
and humans. Physiol Rev. 2006;86(2):565–598.
Parent AS, Teilmann G, Juul A, et al. The timing of
normal puberty and the age limits of sexual precocity.
Endocr Rev. 2003;24(5):668–693.
Rogol AD, Clark PA, Roemmich JN. Growth and
pubertal development in children and adolescents.
Am J Clin Nutr. 2000;72(2 Suppl):521S–528S.
Ahmed ML, Ong KK, Dunger DB. Childhood obesity
and the timing of puberty. Trends Endocrinol Metab.
;20(5):237–242.
Abreu AP, Kaiser UB. Pubertal development and
regulation. Lancet Diabetes Endocrinol. 2016;4(3):
–264.
Global Asthma Network. The Global Asthma Report
Auckland; 2018.
Asher MI, Montefort S, Björkstén B, et al. Worldwide
time trends in asthma prevalence. Lancet. 2006;368:
–743.
Reddel HK, Bateman ED, Becker A, et al. A summary
of the new GINA strategy. Eur Respir J. 2015;46(3):
–639.
Allen DB. Effects of inhaled steroids on growth and
adrenal function. Adv Pediatr. 2006;53:101–110.
Balfour-Lynn L. Growth and childhood asthma. Arch
Dis Child. 1986;61:1049–1055.
Childhood Asthma Management Program Research
Group. Long-term effects of budesonide in children.
N Engl J Med. 2000;343:1054–1063.
Kelly HW, Sternberg AL, Lescher R, et al. Effect of
inhaled glucocorticoids on adult height. N Engl J Med.
;367:904–912.
Rivest S. Interactions between immune and
neuroendocrine systems. Prog Brain Res. 2010;181:
–53.
Ben-Jonathan N, Hugo ER, Brandebourg TD. Prolactin
as a metabolic hormone. Trends Endocrinol Metab.
;17(3):110–116.
Freeman ME, Kanyicska B, Lerant A, Nagy G. Prolactin
regulation. Physiol Rev. 2000;80(4):1523–1631.
Holick MF. Vitamin D deficiency. N Engl J Med.
;357:266–281.
Muscogiuri G, Altieri B, Penna-Martinez M, et
al. Vitamin D and chronic diseases. Endocrine.
;56(3):451–462.
Brehm JM, Celedón JC, Soto-Quiros ME, et al. Vitamin
D and asthma severity. Am J Respir Crit Care Med.
;179:765–771.
Litonjua AA, Weiss ST. Vitamin D and asthma
epidemic. J Allergy Clin Immunol. 2007;120(5):
–1035.
Kadurina TI, Gorbunova VN. Dysplasia of Connective
Tissue. Saint Petersburg; 2009.
Zemtsovsky EV. Undifferentiated connective tissue
dysplasia in children. Pediatrics. 2012;91(4):47–52.
Yakovleva LV, Smirnova GI. Connective tissue
dysplasia and bronchial asthma. Pulmonology.
;26(3):56–63.
Abdullaeva DT, Ilmuratova MA. Asthma in children
with connective tissue dysplasia. O‘zbekiston Harbiy
Tibbiyoti. 2025;(3):34–40.
Prasad AS. Zinc deficiency in humans. Prog Clin Biol
Res. 1983;129:1–33.
Prasad AS. Zinc deficiency: characterization and
treatment. Met Ions Biol Syst. 2004;41:103–137.
Uwitonze AM, Razzaque MS. Magnesium in vitamin
D activation. J Am Osteopath Assoc. 2018;118(3):
–189.
Cinar V, Polat Y, Baltaci AK, Mogulkoc R. Magnesium
supplementation and testosterone. Biol Trace Elem Res.
;140(1):18–23.
Weaver CM, Gordon CM, Janz KF, et al. Peak bone
mass development. Osteoporos Int. 2016;27:1281–1386.
Essential microelements in children with atopic
dermatitis. Am J Educ Learn. 2024;2(5).
Ibáñez L, Oberfield SE, Witchel S, et al. PCOS in
adolescents. Horm Res Paediatr. 2017;88(6):371–395.
Rosenfield RL. Identifying children at risk for PCOS.
J Clin Endocrinol Metab. 2007;92(3):787–796.
Amanzholkyzy A, Donayeva A, Kulzhanova D, et al.
Vitamin D and prolactin in adolescent girls. Arch Med
Sci Civiliz Dis. 2023;8:e202–e206.
Jumanov BA, Zufarova SA. Vitamin D and
reproductive health. Problems of Biology and Medicine.
;3:14–16.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
